{
  "system_prompt": "You are a buy-side equity PM constructing a long-only portfolio from scored candidates.\nRules:\n- Select exactly 20 stocks from the scored candidates provided.\n- Assign weights between 2% and 10% per stock (0.02 to 0.10).\n- Weights must sum to exactly 100% (1.0).\n- Diversify across sectors and industries (respect sector_cap and industry_cap constraints).\n- Prioritize stocks with higher composite scores, but ensure diversification.\n- Consider sector/industry balance and avoid over-concentration.\n- Output must be strict JSON.",
  "user_prompt": "Portfolio Construction Task:\n\n      Investment Horizon: Today to 2026-05-15 (115 days remaining)\n\n      Constraints:\n      - Select EXACTLY 20 stocks\n      - Weight per stock: 2% to 10% (0.02 to 0.10)\n      - Total weight must sum to EXACTLY 100% (1.0)\n      - Sector cap: 35% (no single sector > 35%)\n      - Industry cap: 20% (no single industry > 20%)\n      - Long-only portfolio (no short positions)\n\n      Scored Candidates (sorted by composite score, showing top 40):\n        MRK: score=0.630, sector=Health Care, sentiment=bullish, price=$108.83\n  News: Merck & Co., Inc. (MRK) has recently demonstrated significant advancements in its oncology portfolio, highlighted by a successful five-year study of intismeran autogene in combination with KEYTRUDA, which showed a 49% reduction in recurrence risk for high-risk melanoma patients. The company is also expanding its collaborations, notably with Guardant Health to develop companion diagnostics for new cancer therapies. Analyst upgrades and a strong performance in the oncology sector position MRK favorably, with a recent price target increase to $135. Overall, MRK's stock reflects a solid return trajectory, with a 15.3% increase over the past year.\nGOOGL: score=0.585, sector=Communication Services, sentiment=bullish, price=$330.0, theme=AI and Automation Adoption\n  News: Alphabet Inc. (GOOGL) has garnered positive attention from analysts, with RBC Capital raising its price target from $315 to $375, citing strong momentum in AI advertising and an expanding market for small and medium-sized businesses. The stock has shown impressive long-term performance, with a 69.03% total shareholder return over the past year and a 31.76% return over the last three months. Additionally, Alphabet is recognized as a key player in quantum computing, alongside Microsoft, indicating its commitment to future technologies. Overall, GOOGL remains a strong investment choice amid ongoing advancements in AI and technology sectors.\nAMGN: score=0.575, sector=Healthcare, sentiment=bullish, price=$330.41, theme=Healthcare Innovation and Biotech Advancements\n  News: Amgen (AMGN) has shown strong performance with a 11.7% stock increase over the past three months, driven by robust Q3 earnings and a promising pipeline, including advancements in its weight-loss drug with less frequent dosing. The company is largely controlled by institutional shareholders, which may impact stock price volatility. Recent bullish sentiments highlight Amgen's competitive valuation metrics, with a trailing P/E of 25.18 and a forward P/E of 14.79. Overall, Amgen's solid revenue growth and product pipeline are attracting investor interest amidst a challenging market environment.\nLRCX: score=0.529, sector=Information Technology, sentiment=bullish, price=$222.96\n  News: Lam Research Corporation (LRCX) has received a positive outlook from analysts, with Goldman Sachs raising its price target from $160 to $180 while maintaining a Buy rating, driven by rising semiconductor capital expenditures and memory investments. The semiconductor industry is experiencing a boost from significant capital spending, particularly from TSMC's $54 billion investment in 2026, which is expected to benefit companies like LRCX. As the tech earnings season begins, LRCX is positioned favorably amidst increasing demand for semiconductor equipment, indicating strong growth potential in the near term.\nRMD: score=0.517, sector=Health Care, sentiment=bullish, price=$257.58\n  News: ResMed (RMD) recently reported a quarterly revenue of $1.34 billion, reflecting a 9% year-on-year growth, with earnings per share exceeding analyst expectations. The company has shown strong performance in fiscal 2026, with a recent share price increase of 5.4% over the past month, although it has experienced a 2.8% decline over the last three months. Current valuations suggest a fair value of $258, indicating potential for further growth as interest in sleep and respiratory care continues to rise. Overall, ResMed's financial flexibility and profitability improvements position it favorably in the market.\nREGN: score=0.476, sector=Healthcare, sentiment=bullish, price=$733.04, theme=Healthcare Innovation and Biotech Advancements\n  News: Regeneron Pharmaceuticals (REGN) has experienced mixed short-term returns, with a notable 25.36% increase over the past three months, although it has seen a slight decline of 2.3% over the last week. The company is focusing on in-house innovation rather than pursuing large M&A deals, especially in light of upcoming patent expiries for its lead assets. Additionally, Regeneron's Chief Scientific Officer discussed advancements in gene therapy for hearing loss and plans for weight loss drugs at the recent JP Morgan healthcare conference, indicating ongoing commitment to innovation in its product pipeline.\nCSCO: score=0.460, sector=Information Technology, sentiment=bullish, price=$75.19\n  News: Cisco Systems (NASDAQ: CSCO) has shown positive momentum, with an 8% stock increase over the past three months, driven by strong demand for AI and security solutions, alongside bullish fiscal 2026 guidance. Jim Cramer highlighted the company's recent improvements, suggesting it has 'gotten its act together.' Additionally, Cisco is positioned favorably in the AI infrastructure sector, competing effectively against peers like Dell Technologies. The company's strategic partnerships, such as with Sharon AI and Digital Alpha, further bolster its growth prospects in the evolving digital landscape.\nJNJ: score=0.441, sector=Health Care, sentiment=bullish, price=$218.66\n  News: Johnson & Johnson (NYSE: JNJ) is gaining attention as Jim Cramer expresses optimism about the company's cancer drug portfolio and its upcoming spin-off. The firm recently reported promising Phase 3 data for its antidepressant CAPLYTA, showing improved remission rates in patients with major depressive disorder. As earnings season approaches, JNJ is among the companies expected to report, which could influence investor sentiment amid broader market volatility.\nCL: score=0.435, sector=Consumer Staples, sentiment=neutral, price=$84.52\n  News: Colgate-Palmolive (NYSE:CL) has seen a price target increase from Barclays, rising from $80 to $83, while maintaining an Equal Weight rating, reflecting cautious optimism ahead of its Q4 earnings report scheduled for January 30, 2026. The company is highlighted as one of the Best Dividend Kings to consider for 2026, indicating strong dividend reliability. Additionally, recent analyses suggest that Colgate is navigating a challenging market environment, particularly in comparison to other household product stocks. Investors are advised to monitor upcoming earnings for insights into the company's performance amidst broader market trends.\nNOW: score=0.412, sector=Information Technology, sentiment=bullish, price=$127.31\n  News: ServiceNow (NYSE:NOW) is facing near-term headwinds due to reduced U.S. federal spending, but analysts remain bullish on its long-term prospects, with both Evercore ISI and Oppenheimer maintaining Buy ratings and price targets around $225. The company is enhancing its offerings by integrating biometric security into its platform, which could strengthen its competitive position in mission-critical workflows. Despite being at a one-year low, market sentiment suggests potential upside for investors looking for growth in the tech sector.\nHON: score=0.409, sector=Industrials, sentiment=bullish, price=$219.465\n  News: Honeywell International Inc. (NASDAQ: HON) has recently been upgraded to 'Overweight' by JPMorgan, citing a favorable valuation and improving momentum ahead of a planned corporate breakup. The company's intrinsic value is projected at $250 based on a two-stage free cash flow model. Additionally, Honeywell is exploring an IPO for its quantum computing division, Quantinuum, which could further enhance its market position. Overall, these developments suggest a positive outlook for Honeywell as it navigates significant changes and opportunities in its business segments.\nPFE: score=0.400, sector=Health Care, sentiment=neutral, price=$25.65\n  News: Pfizer (PFE) is gaining investor interest after a year of mixed performance, with a recent 90-day share price return of 3.22% and a total shareholder return of 4.59% over the past year, despite a significant decline of 55% from its peak. The company is focusing on growth in its non-oncology business, particularly with Eliquis, while facing challenges from declining COVID-19 sales. Analysts are debating whether this is a good time to buy the dip, as Pfizer's stock shows signs of recovery amidst broader market trends in the pharmaceutical sector.\nHD: score=0.386, sector=Consumer Discretionary, sentiment=bullish, price=$380.17, theme=Geopolitical Tensions and Trade Policy\n  News: Home Depot (HD) is focusing on enhancing its digital platforms, which are outpacing store growth and driving customer engagement through improved fulfillment and AI tools. Meanwhile, a group of investors is urging the company to reassess its partnership with a surveillance firm amid concerns over the use of customer data in ICE investigations, highlighting potential financial and legal risks. Despite these challenges, Wall Street analysts maintain a generally optimistic outlook on HD, suggesting it remains a favorable investment choice for 2026.\nAAPL: score=0.385, sector=Information Technology, sentiment=bullish, price=$255.517\n  News: Apple (AAPL) recently closed at $255.53, experiencing a mixed performance with a 6.63% decline over the past month and a 5.71% decline year-to-date, despite a strong one-year total shareholder return of 11.61%. Analysts are optimistic, with some projecting a potential rise to $350 by the end of 2026, driven by ongoing consumer demand and technological advancements. The stock's recent pullback has attracted investor attention, prompting discussions on its valuation and long-term return potential. Overall, while short-term fluctuations are evident, the long-term outlook remains positive for Apple amid a competitive tech landscape.\nVZ: score=0.378, sector=Communication Services, sentiment=neutral, price=$38.91\n  News: Verizon Communications (VZ) recently faced significant backlash from over 2 million customers due to a nationwide service outage, which has raised concerns about its impact on customer satisfaction and stock performance. The stock has been under pressure, hitting a 52-week low with a recent decline of 2.29% over the past month, although it has seen a year-to-date return of 3.97%. Investors are closely monitoring the company's response to the outage and its financial metrics, including its return on equity, as they assess the stock's valuation and potential for recovery.\nXOM: score=0.378, sector=Energy, sentiment=bullish, price=$129.89\n  News: ExxonMobil (XOM) is expanding its customer engagement through a new contract with Comarch to modernize loyalty programs in key European markets, which may enhance retail volumes amid increasing competition. The company continues to reward shareholders with rising dividends and buybacks, supported by low-cost assets and manageable debt levels, even as Scotiabank recently lowered its price target for the stock from $155 to $128. Additionally, XOM is investing in exploration with a large seismic survey offshore Trinidad and Tobago, while its share price has shown positive momentum, gaining over 11% in the past month. Overall, ExxonMobil remains a strong player in the energy sector, despite fluctuations in oil prices and market conditions.\nMDT: score=0.377, sector=Health Care, sentiment=bullish, price=$96.76\n  News: Medtronic (MDT) is experiencing positive momentum, with shares up 12.9% over the past year and analysts predicting better-than-expected financial results. The company is actively expanding its product offerings, including a partnership with Precision Neuroscience to enhance surgical systems for brain surgery and the promotion of its Altaviva urinary incontinence device, which has seen significant physician training since its FDA approval. Additionally, MDT is capitalizing on trends in medical technology by focusing on higher-margin products, which are expected to support durable growth and improved earnings quality. Overall, Medtronic's strategic initiatives and market performance position it favorably within the medical device sector.\nHCA: score=0.374, sector=Healthcare, sentiment=bullish, price=$469.29, theme=Demographic Shifts and Aging Population\n  News: HCA Healthcare's stock has demonstrated strong performance, with a 183% increase over the past five years and a recent share price of $469.29, reflecting a 52.3% return over the past year. The company recently appointed Erica Rossitto as the new chief nurse executive, a move that emphasizes clinical leadership amid ongoing expansion. Despite recent fluctuations in short-term performance, analysts suggest that HCA's intrinsic value may be significantly higher than its current share price, indicating potential for future growth. Investors are closely monitoring these developments as they assess HCA's operational strategies and market positioning.\nKO: score=0.363, sector=Consumer Staples, sentiment=neutral, price=$70.44\n  News: Coca-Cola (KO) has decided to abandon its plans to sell Costa Coffee after receiving bids that did not meet expectations, indicating a strategic shift in its portfolio management. The company is focusing on premiumization to enhance revenues and margins, catering to evolving consumer preferences. Currently priced around $70.44 per share, KO has shown a 15.6% total shareholder return over the past year, attracting investor interest amid discussions on dividend stocks for 2026. Additionally, Coca-Cola is actively engaging in community initiatives, such as supporting youth empowerment in Italy ahead of the Milano Cortina 2026 Olympics.\nMSFT: score=0.355, sector=Information Technology, sentiment=bullish, price=$459.86, theme=AI and Automation Adoption\n  News: Microsoft continues to strengthen its position in the quantum computing sector, being recognized alongside Alphabet as a leading player in this emerging technology. Additionally, the company is facing legal challenges from Elon Musk, who is seeking up to $134 billion in damages related to OpenAI's transition to a for-profit model, which could impact Microsoft's reputation and financial standing. Meanwhile, Microsoft partners like Origin Digital are achieving advanced specializations in AI on Azure, highlighting the company's ongoing commitment to AI development and deployment.\nTMO: score=0.349, sector=Health Care, sentiment=bullish, price=$618.72\n  News: Thermo Fisher Scientific Inc. (TMO) has been in the spotlight due to a bullish investment thesis, with analysts raising price targets significantly, reflecting confidence in its growth potential. The company recently announced plans to close its Asheville plant, resulting in over 400 layoffs, which may impact its operational capacity. Despite this, TMO's stock has shown resilience, outperforming the market and maintaining a stable performance with a notable return over the past year. Additionally, partnerships with NVIDIA to enhance AI capabilities in lab workflows indicate a strategic focus on innovation in the life sciences sector.\nMETA: score=0.345, sector=Communication Services, sentiment=neutral, price=$620.25\nNVDA: score=0.343, sector=Information Technology, sentiment=bullish, price=$186.105\n  News: Nvidia's ability to sell its H200 AI chip in China is currently uncertain, as Taiwanese server maker Inventec reported that the decision appears to be stalled on the Chinese side despite U.S. approval. Meanwhile, hedge fund managers have shown renewed interest in Nvidia, purchasing shares in the third quarter, reflecting confidence in its growth potential. However, analysts caution that various risks, including market volatility and ambitious innovation cycles, could impact Nvidia's stock performance moving forward. Additionally, Nvidia is expanding its AI platform beyond gaming into sectors like drug discovery, further diversifying its business opportunities.\nV: score=0.337, sector=Information Technology, sentiment=bullish, price=$328.3\n  News: Visa (V) is facing potential pressure from political scrutiny over credit card swipe fees, particularly following President Trump's proposal for a 10% cap on credit card interest rates. Despite this, analysts remain optimistic, with Citi and Bank of America reaffirming Buy ratings and setting price targets of $450 and $382, respectively. Additionally, Visa is exploring new growth avenues, such as partnerships in the crypto space and a loyalty program with Air Transat, which could enhance its market position. The digital payments sector continues to grow rapidly, driven by increased adoption of fintech solutions and virtual cards.\nMA: score=0.326, sector=Information Technology, sentiment=bullish, price=$539.49\n  News: Mastercard (NYSE: MA) is facing potential challenges following President Trump's proposal to cap credit card interest rates at 10%, which could significantly impact profitability in the credit card industry. Despite this, analysts remain optimistic, with Citi reiterating a Buy rating and setting a price target of $735 for the stock. Additionally, Mastercard's CEO highlighted the company's efforts in combating cybercrime using AI at the World Economic Forum, indicating a focus on innovation amidst regulatory pressures. Overall, while there are headwinds from proposed legislation, analyst sentiment suggests potential for growth in 2026.\nISRG: score=0.326, sector=Health Care, sentiment=bullish, price=$535.068\n  News: Intuitive Surgical (ISRG) is focusing on evolving its da Vinci surgical system into a data-driven platform by integrating AI and software, which may enhance its market position beyond robotics. Despite reporting strong preliminary revenue growth for Q4 and full-year 2025, ISRG's stock experienced a dip as investors assessed procedure trends and future margins. The broader market context includes an upcoming earnings season that may influence investor sentiment across tech stocks, including ISRG.\nQCOM: score=0.322, sector=Information Technology, sentiment=neutral, price=$159.42\n  News: Qualcomm (QCOM) is gaining attention following its recent announcements at CES regarding advancements in AI and robotics, particularly the Dragonwing IQ10 processor. Despite these developments, the company's share price has struggled, reflecting a 10.33% decline over the past week. CEO Cristiano Amon highlighted the company's focus on Edge AI and expansion into industrial and automotive markets, indicating potential growth opportunities. Additionally, Qualcomm declared a quarterly cash dividend of $0.89 per share, reinforcing its commitment to returning value to shareholders.\nANTM: score=0.321, sector=Healthcare, sentiment=neutral, price=$482.58, theme=Demographic Shifts and Aging Population\nPEP: score=0.320, sector=Consumer Staples, sentiment=neutral, price=$146.32\n  News: PepsiCo (PEP) is currently facing challenges in North America, with snack volume pressures prompting the company to focus on permissible snacks and zero-sugar beverages to drive growth. In a strategic move to appease an activist investor, PepsiCo plans to cut about 20% of its snacks and beverages, although specific products to be discontinued have not yet been disclosed. Additionally, the company has maintained a strong dividend history, with an annual payout of $5.69 per share, making it an attractive option for income-focused investors. Notably, Costco has switched back to Coca-Cola products for its food courts, ending a decade-long partnership with PepsiCo, which may impact brand visibility and sales.\nNFLX: score=0.310, sector=Communication Services, sentiment=bullish, price=$88.0\n  News: Netflix (NFLX) is preparing to report its Q4 earnings on January 20, 2026, with expectations of significant stock movement following the results. Despite a recent share price decline of 29.11% over the past 90 days, the company maintains a strong revenue base of $43.38 billion and net income of $10.43 billion. Analysts are optimistic about Netflix's long-term growth potential, given its large user base, while investors are closely monitoring the upcoming earnings report for insights into future performance.\nSHOP: score=0.306, sector=Information Technology, sentiment=bullish, price=$155.81, theme=Consumer Behavior Shifts Post-Pandemic\n  News: Shopify (SHOP) has seen a modest increase in its implied fair value per share, now at approximately $179.49, reflecting optimism around growth and AI-driven monetization strategies. Recent developments include the launch of AI Campaigns by LoyaltyLion to enhance loyalty revenue for Shopify brands, and the introduction of a complete commerce solution for bookstores by Emersoft. Despite a recent retreat in share prices, strong AI adoption and global expansion prospects suggest potential long-term upside for the company. Additionally, unusual options activity indicates heightened investor interest in SHOP amidst a broader market downturn.\nADBE: score=0.290, sector=Information Technology, sentiment=bullish, price=$296.12, theme=AI and Automation Adoption\n  News: Adobe Inc. (NASDAQ: ADBE) has faced significant challenges, with its stock dropping approximately $13 billion recently, contributing to long-term losses for institutional investors who hold substantial stakes in the company. Despite this downturn, some analysts still view Adobe as a buy due to its potential for double-digit growth, discounted valuation, and ongoing share buybacks, even amidst margin pressures. The software sector, including Adobe, has been negatively impacted by fears surrounding new AI tools, leading to a notable decline in software-as-a-service stocks overall. Investors should remain cautious as the market navigates these complexities and the upcoming earnings season.\nLMT: score=0.290, sector=Industrials, sentiment=bullish, price=$582.43\n  News: Lockheed Martin (NYSE:LMT) continues to be a focal point in the defense sector, particularly with its recent scandium supply agreement with Sunrise Energy Metals, which underscores its commitment to securing critical materials for aerospace applications. As the Q3 earnings season wraps up, LMT's performance is being compared to its peers in the defense contracting industry, reflecting ongoing competitive dynamics. Additionally, geopolitical tensions are seen as a potential tailwind for the company, suggesting a favorable outlook for defense spending. However, concerns have emerged regarding potential restrictions on dividends and stock buybacks under new political initiatives.\nSYY: score=0.289, sector=Consumer Staples, sentiment=bullish, price=$78.8\n  News: Sysco Corporation (NYSE:SYY) reported Q3 CY2025 results that met revenue expectations, with a year-on-year sales increase of 3.2% to $21.15 billion and a non-GAAP profit of $1.15 per share, surpassing analyst estimates. Despite a recent price target reduction by Citi from $82 to $81, the stock remains a contender among the best food stocks for 2026. Additionally, Sysco is expanding its distribution network with new partnerships, including a rollout of Beyond Oil products, which may enhance its market position. The company is set to announce its second quarter fiscal year 2026 financial results on January 27, 2026.\nCVX: score=0.269, sector=Energy, sentiment=bullish, price=$166.26\n  News: Chevron (CVX) is poised for potential growth following the U.S. government's expansion of its license in Venezuela and approval for investment in the Leviathan gas field, which could enhance its production capabilities. Analysts remain optimistic, with Jefferies raising its price target for Chevron from $174 to $189 ahead of the company's upcoming earnings report. Despite challenges in Venezuela, Chevron's strategic moves may reshape its production mix and cash generation profile, making it an attractive option in the energy sector.\nABT: score=0.246, sector=Health Care, sentiment=bullish, price=$121.76\n  News: Abbott Laboratories (ABT) is preparing for its Q4 earnings report, with expectations that its adult nutrition segment, particularly Ensure and Glucerna, will drive modest growth. Despite a flat revenue trend over the past 15 months, analysts remain optimistic, with Bernstein raising ABT's price target to $154. However, the stock has recently experienced a decline of approximately 3.3% over the past week, raising questions about its current valuation around $121.76 amidst a broader recovery phase in the healthcare sector.\nWMT: score=0.239, sector=Consumer Staples, sentiment=bullish, price=$119.7, theme=Consumer Behavior Shifts Post-Pandemic\n  News: Walmart has recently received positive attention from RBC Capital, which upgraded its price target to $126 and maintained an Outperform rating, indicating confidence in the stock's potential. Additionally, Walmart-backed PhonePe has secured regulatory approval for its IPO in India, further expanding Walmart's footprint in the fintech sector. However, concerns about the stock's valuation persist, as analysts question whether its high price-to-earnings ratio is justified despite strong business performance. The company is also making strategic moves to attract higher-income shoppers, enhancing its product offerings to better compete with Amazon.\nUNH: score=0.226, sector=Healthcare, sentiment=bullish, price=$331.02, theme=Demographic Shifts and Aging Population\n  News: UnitedHealth Group (UNH) has experienced significant share price declines, with a 33.5% drop over the past year and a recent closing price of $331.02. Amidst ongoing healthcare reform proposals and regulatory scrutiny, Bernstein has identified UNH as a top pick for 2026, suggesting potential for recovery despite current pressures on health insurers. The company recently launched a Rural Payment Acceleration Pilot aimed at supporting independent rural hospitals, which may enhance its market position. Investors are closely monitoring these developments as they reassess the stock's value in light of new policy risks.\nCSX: score=0.220, sector=Industrials, sentiment=neutral, price=$36.235, theme=Infrastructure Investment and Modernization\n  News: CSX has shown relative stability in its stock performance, with a recent share price of $36.25 reflecting a 2.9% gain over the past week and a 12.53% total return over the past year. However, analysts anticipate a decline in earnings for the upcoming Q4 report due to pressures from weaker coal revenues and challenges in merchandise volumes. Despite these concerns, CSX's stock has outperformed competitors on strong trading days, indicating resilience in the market. Investors should monitor the upcoming earnings report closely for insights into the company's performance amid ongoing cost pressures.\nMMM: score=0.209, sector=Industrials, sentiment=neutral, price=$167.8\n  News: 3M (NYSE: MMM) reported its fourth-quarter and full-year 2025 results, alongside initiating financial guidance for 2026. The stock has experienced mixed performance, with a recent decline of 1.93% in a single day, but a 30-day return of 3.61% and a year-to-date return of 3.70%. Investors are closely monitoring the company's valuation amid ongoing litigation uncertainties and broader economic data releases expected this week. Overall, the stock remains on the radar as earnings season ramps up, with significant attention on upcoming reports from other major companies.\n\n      Instructions:\n      1. Select the best 20 stocks considering:\n         - Composite score (higher is better)\n         - Sector diversification (aim for 3-6 sectors, none > 35%)\n         - Industry diversification (none > 20%)\n         - Sentiment alignment (prefer bullish/neutral over bearish)\n         - Theme exposure (balance themed and non-themed stocks)\n\n      2. Assign weights:\n         - Higher scores can get higher weights (up to 10%)\n         - Lower scores should get lower weights (minimum 2%)\n         - Ensure weights sum to exactly 1.0 (100%)\n\n      3. Validate:\n         - Exactly 20 holdings\n         - Each weight between 0.02 and 0.1\n         - Total weight = 1.0\n         - No sector exceeds 35%\n         - No industry exceeds 20%\n\n      Output JSON strictly as:\n      {\n        \"holdings\": [\n          {\n            \"ticker\": \"AAPL\",\n            \"weight\": 0.08,\n            \"sector\": \"Information Technology\",\n            \"theme\": null,\n            \"rationale\": \"High composite score (0.75), strong sentiment, sector leader\",\n            \"composite_score\": 0.75\n          },\n          ... exactly 20 holdings ...\n        ]\n      }",
  "llm_response": {
    "holdings": [
      {
        "ticker": "MRK",
        "weight": 0.1,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Highest composite score (0.630), strong performance in oncology",
        "composite_score": 0.63
      },
      {
        "ticker": "GOOGL",
        "weight": 0.09,
        "sector": "Communication Services",
        "theme": "AI and Automation Adoption",
        "rationale": "Strong momentum in AI advertising, high total shareholder return",
        "composite_score": 0.585
      },
      {
        "ticker": "AMGN",
        "weight": 0.08,
        "sector": "Health Care",
        "theme": "Healthcare Innovation and Biotech Advancements",
        "rationale": "Solid revenue growth and promising pipeline",
        "composite_score": 0.575
      },
      {
        "ticker": "LRCX",
        "weight": 0.08,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Positive outlook from analysts, benefiting from semiconductor investments",
        "composite_score": 0.529
      },
      {
        "ticker": "RMD",
        "weight": 0.07,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Strong quarterly revenue growth and profitability improvements",
        "composite_score": 0.517
      },
      {
        "ticker": "REGN",
        "weight": 0.07,
        "sector": "Health Care",
        "theme": "Healthcare Innovation and Biotech Advancements",
        "rationale": "Focus on in-house innovation and gene therapy advancements",
        "composite_score": 0.476
      },
      {
        "ticker": "CSCO",
        "weight": 0.06,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Strong demand for AI and security solutions, positive guidance",
        "composite_score": 0.46
      },
      {
        "ticker": "JNJ",
        "weight": 0.06,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Promising cancer drug portfolio and upcoming spin-off",
        "composite_score": 0.441
      },
      {
        "ticker": "CL",
        "weight": 0.05,
        "sector": "Consumer Staples",
        "theme": null,
        "rationale": "Strong dividend reliability and cautious optimism ahead of earnings",
        "composite_score": 0.435
      },
      {
        "ticker": "NOW",
        "weight": 0.05,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Bullish long-term prospects despite near-term headwinds",
        "composite_score": 0.412
      },
      {
        "ticker": "HON",
        "weight": 0.05,
        "sector": "Industrials",
        "theme": null,
        "rationale": "Positive outlook with corporate breakup and IPO plans",
        "composite_score": 0.409
      },
      {
        "ticker": "PFE",
        "weight": 0.04,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Focus on growth in non-oncology business, signs of recovery",
        "composite_score": 0.4
      },
      {
        "ticker": "HD",
        "weight": 0.04,
        "sector": "Consumer Discretionary",
        "theme": "Geopolitical Tensions and Trade Policy",
        "rationale": "Enhancing digital platforms and maintaining optimistic outlook",
        "composite_score": 0.386
      },
      {
        "ticker": "AAPL",
        "weight": 0.04,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Long-term outlook remains positive despite short-term fluctuations",
        "composite_score": 0.385
      },
      {
        "ticker": "VZ",
        "weight": 0.03,
        "sector": "Communication Services",
        "theme": null,
        "rationale": "Monitoring customer satisfaction and financial metrics post-outage",
        "composite_score": 0.378
      },
      {
        "ticker": "XOM",
        "weight": 0.03,
        "sector": "Energy",
        "theme": null,
        "rationale": "Expanding customer engagement and rewarding shareholders",
        "composite_score": 0.378
      },
      {
        "ticker": "MDT",
        "weight": 0.03,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Expanding product offerings and focusing on higher-margin products",
        "composite_score": 0.377
      },
      {
        "ticker": "HCA",
        "weight": 0.03,
        "sector": "Healthcare",
        "theme": "Demographic Shifts and Aging Population",
        "rationale": "Strong performance and potential for future growth",
        "composite_score": 0.374
      },
      {
        "ticker": "KO",
        "weight": 0.02,
        "sector": "Consumer Staples",
        "theme": null,
        "rationale": "Focusing on premiumization to enhance revenues and margins",
        "composite_score": 0.363
      }
    ]
  },
  "model": "gpt-4o-mini",
  "timestamp": "2026-01-20T06:22:26.932892"
}